The Centers for Disease Control (CDC) Division for Heart Disease and Stroke Prevention released a new guide for pharmacists looking to publish a collaborative practice agreement (CPA). Collaborative practice agreements are one of pharmacists’ biggest tools in increasing efficiencies in team-based care and formalizing the scope of practice between pharmacists and collaborating prescribers.
This resource is intended to assist pharmacists in implementing a CPA from start to finish that addresses chronic illness. With sixty percent of preventable heart disease and stroke deaths happening to people under age 65, pharmacists can become leading agents in tackling this epidemic by executing preventative care measures bestowed under a pharmacy licensure (Centers for Disease Control and Prevention, 2017).
For purposes of developing a fully comprehensive guide and customizable template, the National Alliance of State Pharmacy Associations (NASPA), American Pharmacists Association (APhA), American Medical Association (AMA), the American Association of Nurse Practitioners (AANP), the Network for Public Health Law – Eastern Region, and University of Maryland Francis King Carey School of Law all partnered with The Centers for Disease Control (CDC) Division for Heart Disease and Stroke Prevention to create this guide, Advancing Team-Based Care through Collaborative Practice Agreements.
Other resources related to collaborative practice agreements can be found here.